FDA Adverse Event Malfunction Summary report: N

ROCHE CARDIAC, TROPONIN T QUANTITATIVE

MDR report key: 4305526 · Received December 8, 2014

Report

Report Number
1823260-2014-09684
Event Type
Malfunction
Date Received
December 8, 2014
Date of Event
November 15, 2014
Report Date
December 8, 2014
Manufacturer
ROCHE DIAGNOSTICS
Product Code
MMI
PMA / PMN Number
K000784
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
DA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THEY RECEIVED AN ERRONEOUS RESULT FOR ONE PATIENT WHO WAS TESTED FOR TROPONIN T QUANTITATIVE (TNT). THE PATIENT WAS INITIALLY TESTED ON A COBAS H232 ANALYZER IN THE AMBULANCE AND THE TNT RESULT WAS "50 - 100.000" NG/L. THE PATIENT WAS BROUGHT TO THE HOSPITAL WHERE HE WAS TESTED USING COBAS 6000 METHODOLOGY AND THE TNT RESULT WAS <10 NG/L. THE <10 NG/L RESULT WAS BELIEVED TO BE CORRECT. THE PATIENT HAD MASSIVE CHEST PAIN DURING THE TIME OF THE EVENT. THE PATIENT HAD BEEN HAVING MILDER PAIN IN THE CHEST AND BACK AREA, BUT THE PAIN SUDDENLY INCREASED. UPON EXAMINATION AT THE HOSPITAL, THE PATIENT SHOWED MILD PAINS. THE PATIENT IS "HEMODYNAMIC STABILE" AS SHOWN BY ECG. THE PATIENT RECEIVED AN "ACUTE KAG" PROCEDURE AND RECEIVED PRETREATMENT FOR "PCI" BASED ON THE ERRONEOUS RESULT. THE PATIENT RECEIVED A MAGNYL TABLET, A BRILIQUE TABLET, AND IV HEPARIN. THE PATIENT WAS INCLUDED IN A "NONSTEMI" STUDY. THE PATIENT'S CURRENT CONDITION IS "STATUS QUO". THE PATIENT WAS NOT HARMED BY AN ACTIONS TAKEN. RETENTION MATERIALS WERE INVESTIGATED AND THE RESULTS FROM RETENTION TESTING MEET REQUIREMENTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
790366 ROCHE CARDIAC, TROPONIN T QUANTITATIVE IMMUNOASSAY METHOD, TROPONIN SUBUNIT MMI ROCHE DIAGNOSTICS NA 28167515

Patients

Seq Age Sex Outcome Treatment
1 039 YR